Rats gavaged with monocrotaline, 160 mgkg, were killed between days 1 and 10. Two central veins are seen with reduced lumen size. Venoocclusive liver disease after bone marrow transplantation. This chapter focuses on hepatic veno occlusive disease with immunodeficiency vodi, including the historic and scientific background, clinical. Continued or relapsing disease for 6 months hallmark of hcv fulminant hepatitis progression to hepatic failure within 2 3 weeks in the us, most commonly hav and hbv adults carrier state harbor replicating virus and can transmit the organism. The pathology of noncirrhotic liver diseases causing portal hypertension such as extrahepatic portal obstruction, idiopathic portal hypertension, nodular regenerative hyperplasia, veno occlusive disease, and buddchiari syndrome is mainly explained. This is a pdf file of an unedited manuscript that has been accepted for publication. Hepatic venoocclusive disease vod as a distinct clinical entity was first.
Sinusoidal obstruction syndrome or hepatic venoocclusive disease is a rare disease. Characterization of a reproducible rat model of hepatic veno. Hepatic venoocclusive disease an overview sciencedirect topics. In no other medical situation is a patient at risk for so many liver diseases as during a hematopoietic cell. The blockage leads to high blood pressures in the arteries of the lungs, which, in turn, leads to heart failure. Hepatic veno occlusive disease is a leading cause of morbidity and mortality after haemopoietic stemcell transplantation hsct. When linked to hematopoietic transplant, over thirty percent cases prove to be fatal with a high mortality rate of the severe cases. Hepatic veno occlusive disease is a condition that blocks occludes small veins in the liver, disrupting blood flow in this organ. Radiationinduced liver disease rild remains poorly understood and treated because of the lack of suitable animal models. Pathology of noncirrhotic liver disease springerlink. It accounts for a significant fraction of transplantrelated mortality and, in its severe form, is almost always fatal. Hepatic veno occlusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed.
A trichrome stain of the liver is shown that demonstrates fibrosis as blue. As the diagnosis is based on clinical criteria, the. The clinical syndrome of hvod is characterized by painful hepatomegaly, fluid avidity, increased weight gain, and jaundice. Hepatic venoocclusive disease vod or sinusoidal obstructive syndrome sos is a disorder characterised by obstruction of small intra hepatic venules and damage to the surrounding centrilobular hepatocytes and sinusoids. In other cases, for example a patient with chronic hepatitis c. Hepatic veno occlusive disease was examined by scanning electron microscopy sem. Liver histology demonstrates obstruction of sinusoids in central areas with hepatocyte necrosis and hemorrhage. A case of fulminant hepatic failure leading to death in a patient receiving dtic for metastatic melanoma is presented. The pathological differential diagnosis of portal hypertension.
Pdf in a retrospective study of autopsy material, 2 cheetahs and 3 snowleopards showed occlusive lesions of the centrilobular and sublobular hepatic. The clinical syndrome of hepatic venoocclusive disease vod after haemopoietic stem cell transplantation sct is characterized by liver enlargement and pain, fluid retention, weight gain, and jaundice mcdonald et al, 1984. Defibrotide in the treatment of hepatic venoocclusive disease. Jul 01, 2006 hepatic veno occlusive disease immunodeficiency syndrome is characterized by the association of severe hypogammaglobulinemia, combined t and b cell immunodeficiency, absent lymph node germinal centers, absent tissue plasma cells and hepatic veno occlusive disease. Veno occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies. The veno occlusive disease of the liver vod is a disorder caused by the nonthrombotic occlusion of the central veins of hepatic lobules. Venoocclusive disease was unwittingly first described in south africa in the 1920s, secondary to senecio poisoning. Hepatic veno occlusive disease is a lifethreatening condition in which toxic substances either chemotherapeutic drugs or pyrrolizidine alkaloids found in various herbal remedies cause severe damage to the endothelial cells of sinusoidal vessels in the liver, resulting in massive fibrosis and blood flow obstruction. Sinusoidal obstruction syndrome sos is a rare liver disorder due to hepatic vascular injury. In severe cases, multiple organ failure or severe bacterial infections may occur. Public users are able to search the site and view the abstracts for each book and.
Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, is a condition arising from occlusion of hepatic venules. Hepatic venoocclusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed. Li2 normal histology li21 lobulation li22 acinar structure li23 normal bile ducts li24 liver muralium li25 the portal and septal space li26 hepatic veins. Dec 30, 2003 lack of a reproducible animal model has hampered progress in understanding hepatic veno. Reports of hepatic venoocclusive disease in patients undergoing bone. Noninvasive imaging diagnosis of sinusoidal obstruction. This chapter focuses on hepatic venoocclusive disease with immunodeficiency vodi, including.
Poisoning associated with herbal teas arizona, washington. Hepatic venoocclusive disease after bone marrow transplantation. A child presented with hepatic veno occlusive disease after having been administered a short course of treatment with a traditional herbal remedy. Hepatic outflow obstruction, congestive hepatopathy, and the development of cirrhosis. Hepatic venoocclusive disease with immunodeficiency oxford.
Aboincompatible plasma causing hepatic veno occlusive disease in hsct erin meyer, do, mph assistant medical director of blood, tissue, and apheresis services childrens healthcare of atlanta assistant professor of pathology and lab medicine emory university school of medicine 37. Pulmonary veno occlusive disease pvod is a rare form of pulmonary hypertension caused by progressive blockage of the small veins in the lungs. Hepatic veno occlusive disease with immunodeficiency also called vodi is a hereditary disorder of the liver and immune system. Characterization of a reproducible rat model of hepatic veno occlusive disease laurie d. Hepatic veno occlusive disease is an uncommon mar 31, 2016 the laboratory workup of a patient with possible veno occlusive disease has several objectives.
Veno occlusive disease of the liver after marrow transplantation. Hepatic venoocclusive disease or sinusoidal obstruction syndrome. Here, we present a case of neuroblastoma with pvod following hvod after. Tusanqirelated sinusoidal obstruction syndrome in china. Immunohistochemical identification of the material within occluded central venules. The clinical features are similar to those of intrahepatic portal hypertension unexplained weight gain, ascites, painful hepatomegaly, jaundice. It is a complication of highdose chemotherapy given before a bone marrow transplant bmt and is marked by weight gain due to fluid retention, increased liver size, and raised levels of bilirubin in the blood. This causes a decrease in blood flow inside the liver and may lead to liver damage. Hepatic venoocclusive disease can occur at any age.
As a service to our customers we are providing this early version of the manuscript. Understanding the similarities and differences between hepatic. Pdf diagnosis and severity criteria for sinusoidal obstruction. The smaller vein shows obliteration of the lumen without complete scarring red arrow. Finely nodular liver minimal parenchymal regeneration veno occlusive disease. Hepatic sinusoidal obstruction syndromeveno occlusive disease sosvod. The outlook for hepatic venoocclusive disease depends on the causative factor of the condition. Hepatic venoocclusive disease an overview sciencedirect. Fulminant liver failure due to severe venoocclusive disease. Nineteen patients had documented venoocclusive disease, nine had hepatic graftvshost disease gvhd five after proved venoocclusive disease, two had hepatitis, and 40 had no clinical or biochemical evidence of liver injury after bone marrow transplantation. Symptoms include hyperbilirubinemia, painful hepatomegaly and ascites. There are no effective treatments for liver cancer patients who.
What is hepatic venoocclusive diseasecausessymptoms. Apr 09, 2018 hepatic veno occlusive disorder or hepatic vod in a medical condition in which the sinusoidal capillaries present within the liver undergo injury due to consumption of toxic entities like pyrrolizidine alkaloids or oral chemotherapeutic agents which is present in herbal tea. Primary immunodeficiency diseases are inherited disorders that affect human adaptive and innate immunity. Hepatic venoocclusive disease with immunodeficiency also called vodi is a hereditary disorder of the liver and immune system. A comprehensive approach to hepatic vascular disease. Veno occlusive disease and sinusoidal obstruction syndrome.
Veno occlusive disease of the liver with two fatal cases. Hepatic venoocclusive disease with immunodeficiency. Hepatic venoocclusive disease immunodeficiency syndrome is characterized by the association of severe hypogammaglobulinemia, combined t and b cell immunodeficiency, absent lymph node germinal centers, absent tissue plasma cells and hepatic venoocclusive disease. The clinical diagnosis may be quite accurate as confirmed by biopsy or autopsy and is based on the triad of jaundice, hepatomegaly andor right upper quadrant pain, and ascites or unexplained.
This study aimed to investigate the hypothesis that the herbal remedy was the cause of veno occlusive disease. The lancet original articles veno occlusive disease of the liver essential pathology g. Pathology of noncirrhotic liver disease request pdf. Hepatic venoocclusive disease vod, also known as sinusoidal obstruction syndrome sos, is a condition arising from occlusion of hepatic venules.
Interpretation of liver biopsy findings depends very much on clinicopathological correlation. When the condition arises due to ingestion of cytotoxic agents, then the condition has a. Early histology changes of sinusoidal obstruction syndrome. Unfortunately, such criteria are not highly specificity and fail to provide a timely. Defibrotide was approved earlier by the european medicines agency for the same indication. Management of hepatic venoocclusive disease vod background. Sos is often established clinically, based on baltimore, modified seattle, or european society for blood and marrow transplantation ebmt criteria. Occlusive venous lesions in alcoholic liver disease. Hepatic venoocclusive disease induced by chinese medicinal herbs. Yeh, in macsweens pathology of the liver seventh edition, 2018. Robbins and cotran pathologic basis of disease 2010, 8th ed. Autopsy revealed widespread centrilobular necrosis secondary to a veno. The clinical syndrome of hepatic veno occlusive disease vod after hematopoietic stem cell transplantation sct is characterized by liver enlargement and pain, fluid retention, weight gain and jaundice 1, 2, 3.
Professor of pathology university college of the west indies, jamaica several diseases of the liver, though of different pathogenesis, possibly have a common factore. Oct 30, 2014 the lack of hepatic veno occlusive disease in other forms of inherited immunodeficiency suggest that this is a primary feature of vodi. In developed countries, hepatic venoocclusive disease is mainly associated with the conditioning regimen for hematopoietic stem cell transplantation, with 10 to 60% of transplant patients depending on the conditioning regimen protocol used developing hepatic vod. Characterization of a reproducible rat model of hepatic. Clinical presentation right upper quadrant pain painful hepatomegaly ascites abnormal liver. The laboratory workup of a patient with possible veno occlusive disease has several objectives. Its onset is typically by day 30 after sct, although later onset has been described lee et al, 1997. Hepatic venoocclusive disease originating in ecuador. In some cases, a liver biopsy may be taken in order to reach a primary diagnosis.
Management of hepatic veno occlusive disease vod background. Indira sahdev, hisham abdelazim, in lanzkowskys manual of pediatric hematology and oncology sixth edition, 2016. Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, represents the most frequent complication in patients in early phase following hematopoietic stemcell. Pdf hepatic venoocclusive disease antonio ruggiero. Hepatic veno occlusive disease after bone marrow transplantation. The central role of the sp110 mutation in vodi, along with identification of novel mutations and key. Clinical signs and symptoms of veno occlusive disease include hepatomegaly, right.
The current understanding of the pathophysiology of. Pvod can occur in connection with highdose chemotherapy or hematopoietic stem cell transplantation, similar to hepatic veno occlusive disease hvod. Hepatic veno occlusive disease vod, increasingly referred to as sinusoidal obstruction syndrome, is a wellrecognized complication of hematopoietic stem cell transplantation and contributes to considerable morbidity and mortality. Hepatic veno occlusive disease is caused by ingestion of certain species of plants belonging to the genera senecio, crotalaria, heliotropium, and cynoglossum. Sinusoidal obstruction syndrome hepatic venoocclusive disease. Sinusoidal obstruction syndrome sos, previously known as veno occlusive disease vod, is a distinctive and potentially fatal form of hepatic injury that occurs predominantly, if not only, after drug or toxin exposure. In contrast to this, our experience is that these lesions can be found frequently in sections of liver taken at autopsy from patients with alcoholic liver disease. Venoocclusive hepatic disease differential diagnoses. Low molecular weight heparin for the prevention of veno occlusive disease of the liver in bone marrow transplantation. Orloff, in blumgarts surgery of the liver, biliary tract and pancreas, 2volume set sixth edition, 2017. Aboincompatible plasma causing hepatic venoocclusive disease in hsct erin meyer, do, mph assistant medical director of blood, tissue, and apheresis services childrens healthcare of atlanta assistant professor of pathology and lab medicine emory university school of medicine 37. Sem correlated its histology and postmortem examination and.
Sinusoidal obstruction syndrome venoocclusive disease ncbi. Hepatic complications of hematopoietic cell transplantation. Hepatic venoocclusive disease is caused by ingestion of certain species of plants belonging to the genera senecio, crotalaria, heliotropium, and cynoglossum. Sinusoidal obstruction syndrome venoocclusive disease livertox. Pathology outlines sinusoidal obstruction syndrome.
Hvod pathophysiology is associated with endothelial cell damage triggered by cytotoxic chemotherapy. Its rapid and accurate diagnosis is crucial for patient survival. This article characterizes a reproducible model of hvod. In developed countries, hepatic veno occlusive disease is mainly associated with the conditioning regimen for hematopoietic stem cell transplantation, with 10 to 60% of transplant patients depending on the conditioning regimen protocol used developing hepatic vod.
The pathology of noncirrhotic liver diseases causing portal hypertension such as extrahepatic portal obstruction, idiopathic portal hypertension, nodular regenerative hyperplasia, veno occlusive. Hepatic venoocclusive disease, or sinusoidal obstruction syndrome, is a common and potentially fatal complication following hsct. Pdf venoocclusive disease vod of the liver in cheetah. Know the causes, symptoms, treatment and prognosis of hepatic venoocclusive disease. Liver venoocclusive disease an overview sciencedirect topics.
Hepatic vein occlusive disease hvod is a rare complication after liver transplantation, with complicated pathogenesis and poor prognosis. Hepatic veno occlusive disease, or sinusoidal obstruction syndrome, is a common and potentially fatal complication following hsct. We aimed to assess whether defibrotide can reduce the incidence of. It is a complication of highdose chemotherapy given before a bone marrow transplant bmt and is marked by weight gain due to fluid r. Vod is defibrotide,84,85 a novel polydeoxyribonucleotide with adenosine. Clinical presentation pathology radiographic features treatment and prognosis references. Pdf the advances in hematopoietic cell transplantation hct over the last decade have led to a transplantrelated mortality below 15%.
Abstract a 23 year old man presented with hepatic veno. Nov 01, 2008 in severe cases, multiple organ failure or severe bacterial infections may occur. The first goal, of course, is to confirm the diagnosis, the second goal is to look for a detectable discrete cause, and the third goal is to establish the function of the liver and other end organs. In most cases, affected individuals experience recurrent infections, but they may also suffer from autoimmune diseases and malignancies. Light microscopy and hepatic angiography showed occlusion of sublobular veins and small venous radicles of the liver, associated with widespread haemorrhagic necrosis of hepatocytes. In the western hemisphere, vod, classified as a conditioningrelated toxicity, is most commonly caused. The clinical syndrome of hepatic venoocclusive disease vod after hematopoietic stem cell transplantation hsct is characterized by liver enlargement and pain, fluid retention, weight gain, and jaundice. A reticulin stain reveals the marked deposition of collagen within the lumen of the central vein. Veno occlusive lesions in alcoholic liver disease have only rarely been mentioned in the literature and are generally thought to be of little significance 35. Its signs and symptoms appear after the first few months of life. Venoocclusive disease of the liver pubmed central pmc. Sinusoidal obstruction syndrome venoocclusive disease. Pulmonary veno occlusive disease pvod is an uncommon form of pulmonary hypertension that is usually difficult to diagnose and is refractory to conservative treatment. Sos can present in an acute, subacute or chronic form usually with abdominal pain and swelling, with evidence of portal hypertension and variable degrees of serum.
This chapter focuses on hepatic veno occlusive disease with immunodeficiency vodi, including. Hepatic venoocclusive disease is a pathological condition in which there is blockage of minute veins in the liver. Numerous novel tools show promise in facilitating the diagnosis of hvod. Postmortem liver histology confirmed the diagnosis. Veno occlusive disease of liver with nonportal type of cirrhosis, occurring in jamaica. Also called sinusoidal obstruction syndrome, vod is a group of disorders in which hepatic venous outflow obstruction is caused by subendothelial sclerosis of the sublobular hepatic veins, terminal hepatic venules, and sinusoids. A reticulin stain reveals the parenchyma framework of the lobule and the marked deposition of collagen within the lumen of the central vein. Hepatic venoocclusive disease radiology reference article. Kanel4 lack of a reproducible animal model has hampered progress in understanding hepatic veno occlusive disease. Hepatic venoocclusive disease sinusoidal obstruction syndrome. Early clinical predictors of hepatic veno occlusive disease sinusoidal obstruction syndrome after myeloablative stem cell transplantation. Fig 8 veno occlusive disease sinusoidal obstructive syndrome. Hepatic veno occlusive disease vod or sinusoidal obstructive syndrome sos is a disorder characterised by obstruction of small intra hepatic venules and damage to the surrounding centrilobular hepatocytes and sinusoids.
Hepatic venoocclusive disease sinusoidal obstruction. Fundamental liver pathology part 1 duke university. It is the first drug to be approved by the fda for treatment of severe hepatic veno occlusive disease. Prophylactic heparin does not prevent liver veno occlusive disease following autologous bone marrow transplantation. Interprofessional skills challenge for a potential post. Management of hepatic vein occlusive disease after liver. In 2006, roscioli et al 1 described mutations in the promyelocytic leukemia protein pml nuclear body protein sp110 in six children from five families of lebanese ethnicity, who met the clinical criteria for. Hepatic venoocclusive disease genetic and rare diseases. A case of pulmonary venoocclusive disease following. Sinusoidal obstruction syndrome hepatic venoocclusive.